Skip to main content

 Research

Our research plan for the next five years

First: solving environmental problems:

  • Interstitial pulmonary fibrosis including recent diagnostic tools like transbronchial cryobiopsy and thoracoscopic lung biopsy.
  • Rehabilitation of chronic lung diseases especially COPD and interstitial pulmonary fibrosis with establishment of new unit for this purpose.
  • Lower respiratory tract infections: identification of the causative organisms in our localities and the resistance problems.
  • T.B especially the resistance problem in our locality and the new diagnostic tools.
  • Establishment of the rose technique in our bronchoscopy unit.
  • Researches in asthma and COPD with references to their prevalence and recent therapeutic options.

Second: developing diagnosing tools

  • Interventional pulmonology.
  • Imaging modalities.
  • Pulmonary hypertension.
  • Endoscopic lung volume reduction techniques.
  • Lower respiratory tract infections.
  • Tuberculosis
  • Sleep medicine.

Third: Preparing specialized cadres in the different chest units.

  • The department encourages joint research between the chest department and other clinical and academic departments with different colleges and universities.
  • In the next five-year plan, the Council adopts the research presented by the faculty and supervisors the master's and doctoral theses after presenting the research protocol for each thesis in the scientific session, which is held weekly in the department.
# Title Research Year
121 Pulmonary haemodynamics and gasometric parameters associated with
exercise induced oxygen desaturation in idiopathic pulmonary fibrosis
2017
122 Role of MRI Apparent Diffusion Coefficient (ADC) Quantification in the differentiation between benign and malignant pulmonary lesions 2017
123 Role of MRI Apparent Diffusion Coefficient (ADC) Quantification in the differentiation between benign and malignant pulmonary lesions 2017
124 Role of MRI Apparent Diffusion Coefficient (ADC) Quantification in the differentiation between benign and malignant pulmonary lesions 2017
125 Role of plasma miRNA155 and miRNA 197 as tumor markers for lung cancer 2017
126 The presence and types of sleep disordered breathing in ischemic, hypertensive and cardiomyopathic heart failure patients 2017
127 The presence and types of sleep disordered breathing in ischemic, hypertensive and cardiomyopathic heart failure patients 2017
128 The presence and types of sleep disordered breathing in ischemic, hypertensive and cardiomyopathic heart failure patients 2017
129 The presence and types of sleep disordered breathing in ischemic, hypertensive and cardiomyopathic heart failure patients 2017
130 Total antioxidant capacity as a marker in predicting severity of
chronic obstructive pulmonary diseases
2017